At what point can bupropion be initiated when tapering off sertraline 100 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Transitioning from Sertraline to Bupropion: Timing and Protocol

When switching from sertraline 100 mg to bupropion, you should gradually taper sertraline while starting bupropion after sertraline is reduced to 50 mg or lower to minimize risk of serotonin syndrome and withdrawal effects. 1, 2

Tapering Sertraline Protocol

  • Begin by reducing sertraline from 100 mg to 50 mg daily for 1-2 weeks while monitoring for withdrawal symptoms 1
  • SSRIs including sertraline should always be slowly tapered when discontinued to minimize risk of withdrawal effects 1
  • Abrupt discontinuation or major dose reduction is unacceptable medical care and can lead to significant adverse effects 1
  • The standard effective dose of sertraline is 50 mg daily, making this a reasonable intermediate step in the taper 3

Initiating Bupropion

  • Start bupropion only after sertraline has been reduced to 50 mg or lower to minimize risk of drug interactions 2
  • For Bupropion SR (sustained release), begin with 150 mg once daily for 3 days, then increase to the standard maintenance dose of 150 mg twice daily if tolerated 4
  • For Bupropion XL (extended release), start with 150 mg once daily, with a maintenance dose of 150-300 mg once daily 4
  • Monitor closely during the first 1-2 weeks after initiating bupropion for adverse effects, including agitation, irritability, or unusual changes in behavior 1

Completing the Transition

  • After 1-2 weeks of combined therapy at lower doses, further reduce sertraline to 25 mg daily for 1 week before complete discontinuation 1
  • Continue bupropion at the established effective dose (typically 300 mg daily for SR formulation or 150-300 mg for XL formulation) 4, 5
  • Assess therapeutic response to bupropion after 4-6 weeks of treatment at the target dose 5

Special Considerations and Cautions

  • There is a risk of serotonin syndrome when combining bupropion with sertraline, particularly at higher doses of both medications 2
  • Early symptoms of serotonin syndrome can include myoclonic jerks, confusion, and alternating agitation and lethargy, which might be misinterpreted as worsening depression 2
  • Bupropion may be particularly beneficial for patients concerned about sexual dysfunction, as it has significantly lower rates of sexual side effects compared to sertraline (15% vs 63% in men; 7% vs 41% in women) 6, 7
  • Bupropion is contraindicated in patients with seizure disorders as it lowers the seizure threshold 4, 5
  • Avoid combining with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOIs 4

Monitoring During Transition

  • Monitor patients closely during the first 1-2 weeks of the transition for both withdrawal symptoms from sertraline and adverse effects from bupropion 1
  • Assess for emergence of agitation, irritability, unusual changes in behavior, or suicidal thoughts, as these can indicate worsening depression or adverse medication effects 1
  • If intolerable withdrawal symptoms occur during sertraline taper, slow the taper rate further 1
  • If adverse effects from bupropion occur, consider maintaining a lower dose (150 mg daily) until sertraline is completely discontinued 4

This protocol prioritizes patient safety by minimizing the risk of drug interactions while ensuring effective treatment of depression throughout the transition period.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Sertraline 50 mg daily: the optimal dose in the treatment of depression.

International clinical psychopharmacology, 1995

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Other Antidepressants.

Handbook of experimental pharmacology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.